Mercy Cancer Center-Elyria — Elyria, Ohio

Mercy Cancer Center-Elyria is a clinical research site located in Elyria, Ohio, United States 44035.

Crixeo Clinical Trials Trust Score: 31/100 (FAILING). This profile has not yet been claimed by the site owner.

Mercy Cancer Center-Elyria has participated in 103 clinical trials with 44 currently active.

Therapeutic areas: Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7.

Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Elyria

Browse all research sites in Ohio · View every site in Elyria

Sponsor Feasibility Report

Trust Score: 31/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mercy Cancer Center-Elyria?

Mercy Cancer Center-Elyria has a Crixeo Trust Score of 31/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mercy Cancer Center-Elyria conducted?

Mercy Cancer Center-Elyria has 103 clinical trials on record, with 44 currently active. Their work covers Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7.

Is Mercy Cancer Center-Elyria accredited by Crixeo Clinical Trials?

Mercy Cancer Center-Elyria has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mercy Cancer Center-Elyria?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.